Wade, A. J. http://orcid.org/0000-0002-8499-8490
Doyle, J. S.
Gane, E.
Stedman, C.
Draper, B.
Iser, D.
Roberts, S. K.
Kemp, W.
Petrie, D.
Scott, N.
Higgs, P.
Agius, P. A.
Roney, J.
Stothers, L.
Thompson, A. J.
Hellard, M. E.
Funding for this research was provided by:
AbbVie
Article History
Received: 25 August 2017
Accepted: 27 June 2018
First Online: 16 July 2018
Ethics approval and consent to participate
: This study received ethics approval from St Vincent’s Hospital (Melbourne) Human Research Ethics Committee (HREC-D 080/15). Every participant provided informed consent and signed an approved patient information and consent form.
: This manuscript contains no individual person’s data.
: BD, NS, JR – none. AW receives funding for investigator-initiated research from AbbVie. LS reports research funding – Janssen, and speaker – Roche and MSD.MH receives funding for investigator-initiated research – Gilead, BMS and AbbVie. PH receives funding for investigator-initiated research – Gilead, AbbVie.SR reports being an advisory board member – Gilead, MSD, Bayer, AbbVie and speaker: Gilead, Bayer and PI – Gilead, MSD, Bayer, AbbVie, BMS, Janssen, Arbutus, Assembly Biosciences, Intercept, GSK, NGM pharmaceuticals. WK receives funding from – Gilead, BMS, MSD, AbbVie and PI – DURECT, Arena Pharmaceuticals, MSD. JD receives funding for investigator-initiated research from Gilead, BMS and AbbVie and reports payments to institution for consulting from Merck, BMS, Gilead. DI reports being an advisory board member – AbbVie, BMS, MSD, and speaker – AbbVie, BMS, Gilead, MSD, and PI – Gilead, MSD; CS reports being an advisory board member – AbbVie, MSD, Gilead, and speaker – Gilead, AbbVie, and PI – Gilead, MSD, AbbVie, Janssen, Achillion. AT reports being an advisory board member – Gilead, AbbVie, Bristol-Myers Squibb (BMS), and Merck, and speaker – Gilead, Merck, BMS, AbbVie, Roche Diagnostics, and PI – Gilead, Merck, AbbVie, BMS, Genfit, Arrowhead, Spring Bank, Sillajen, and research / grant support – Gilead, Merck, BMS, AbbVie, Bayer. EG reports being an advisory board member – Gilead, Janssen, AbbVie and speaker: Gilead, AbbVie.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.